Growth Metrics

Nu-Med Plus (NUMD) EBIT Growth (1y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Nu-Med Plus - - - -5.02%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -5.02%
Sep 30, 2025 42.15%
Jun 30, 2025 35.04%
Mar 31, 2025 9.13%
Dec 31, 2024 83.20%
Sep 30, 2024 -14.99%
Jun 30, 2024 30.48%
Mar 31, 2024 23.70%
Dec 31, 2023 -765.44%
Sep 30, 2023 73.91%
Jun 30, 2023 60.27%
Mar 31, 2023 54.79%
Dec 31, 2022 94.31%
Sep 30, 2022 50.96%
Jun 30, 2022 76.96%
Mar 31, 2022 83.28%
Dec 31, 2021 77.78%
Sep 30, 2021 73.68%
Jun 30, 2021 72.26%
Mar 31, 2021 -138.93%
Dec 31, 2020 -145.73%
Sep 30, 2020 -207.60%
Jun 30, 2020 -272.65%
Mar 31, 2020 64.76%
Dec 31, 2019 42.12%
Sep 30, 2019 71.99%
Jun 30, 2019 -44.50%
Mar 31, 2019 -197.22%
Dec 31, 2018 -109.12%
Sep 30, 2018 -279.00%
Jun 30, 2018 -51.58%
Mar 31, 2018 -104.46%
Dec 31, 2017 314.69%
Sep 30, 2017 80.20%
Jun 30, 2017 37.46%
Mar 31, 2017 -6.19%
Dec 31, 2016 15.79%
Sep 30, 2016 -129.36%
Jun 30, 2016 54.29%
Mar 31, 2016 44.67%
Dec 31, 2015 253.11%
Sep 30, 2015 -26.97%
Jun 30, 2015 -96.31%
Mar 31, 2015 33.70%
Sep 30, 2014 -172.31%
Jun 30, 2014 -484.84%
Mar 31, 2014 -122.30%
Mar 31, 2013 -312.02%